Latest Administration News

Page 152 of 164
Magnum Mining and Exploration Limited reported a net cash outflow of $87.68k for Q4 2024, ending the quarter with $332.81k in cash and a substantial $11 million in unused financing facilities.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Alterity Therapeutics has reported positive Phase 2 results for ATH434, showing significant slowing of Multiple System Atrophy progression and a favorable safety profile. The trial demonstrated clinical benefits alongside reductions in brain iron accumulation, a key disease driver.
Ada Torres
Ada Torres
30 Jan 2025
Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.
Ada Torres
Ada Torres
30 Jan 2025
NSX Limited reports a $1.6 million cash injection from ISXFEU, completes the ClearPay joint venture sale, and reduces operational costs in its 2Q25 activities report, while facing delays in share issuance approval.
Claire Turing
Claire Turing
30 Jan 2025
Galena Mining Limited reports a challenging December quarter at its 60%-owned Abra Base Metals Mine, marked by production declines and ongoing voluntary administration. The company appoints a new CEO for Abra and explores recapitalisation options to stabilise operations.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Impact Minerals reports a maiden Measured Resource at its Lake Hope High Purity Alumina Project and secures $2.87 million in government funding to accelerate pilot plant development, while progressing exploration and IPO plans for other assets.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Bluechiip Limited advances its strategic repositioning with a new licensing agreement valued up to USD 750,000 alongside ongoing efforts to lift its trading suspension and grow sales.
Ada Torres
Ada Torres
30 Jan 2025
Zelira Therapeutics has secured a fourth funding tranche of US$681,000, advancing its HOPE® Autism Spectrum Disorder FDA trial process and bringing total funding to US$3.25 million. The company is progressing clinical validation and product development, including the transformation of Zenivol® into a capsule formulation.
Ada Torres
Ada Torres
30 Jan 2025
Echo IQ Limited has secured FDA clearance for its EchoSolv AS technology and appointed a US-based CEO, marking a pivotal shift towards commercialisation in the American healthcare market.
Ada Torres
Ada Torres
30 Jan 2025
MFF Capital Investments Limited has announced a fully franked ordinary dividend of AUD 0.08 per share, payable in May 2025, alongside shareholder-friendly reinvestment and bonus security plans.
Claire Turing
Claire Turing
30 Jan 2025
Latin Resources Limited has completed the demerger of its non-core mineral exploration assets into ESG Minerals Limited, distributing shares to eligible shareholders and refocusing its portfolio.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Tlou Energy Limited reported a challenging quarter with significant cash outflows from operations and investing activities, while actively pursuing additional funding to sustain its exploration efforts.
Maxwell Dee
Maxwell Dee
30 Jan 2025